We got some love in Japan regarding the second article in Nature.
https://aasj.jp/news/watch/24633
Last paragraph translation:
I didn't expect MSC to be made from iPS cells and made into a product when I was active, but using the fact that I can increase cells almost infinitely at the iPS cell stage, it was difficult to realise with cell therapy, complete one type of cell product that can be used all over the world. I think the most important point is to make it happen. I think the FDA's approval is probably near, so I'm happy that an iPS cell-derived cell product that can be used for universal use has finally been born.
Ann: Further GvHD Clinical Data Published in Nature Medicine, page-11
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
-0.005(2.86%) |
Mkt cap ! $38.41M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 17.5¢ | 17.0¢ | $42.82K | 247.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 141820 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 58088 | 1 |
View Market Depth
| Last trade - 14.00pm 07/08/2025 (20 minute delay) ? |
| CYP (ASX) Chart |